-
1
-
-
0025987977
-
Oxidative stress: From basic research to clinical application
-
Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991; 91: 31S-38S.
-
(1991)
Am J Med
, vol.91
, pp. 31S-38S
-
-
Sies, H.1
-
2
-
-
46049091026
-
Introduction. Oxidative stress and heart disease
-
Bhatt DL, Pashkow FJ. Introduction. Oxidative stress and heart disease. Am J Cardiol 2008; 101: 1D-2D.
-
(2008)
Am J Cardiol
, vol.101
, pp. 1D-2D
-
-
Bhatt, D.L.1
Pashkow, F.J.2
-
3
-
-
33748428472
-
Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo
-
Yada T, Shimokawa H, Hiramatsu O, Haruna Y, Morita Y, Kashihara N, et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol Heart Circ Physiol 2006; 291: H1138-H1146.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.291
, pp. H1138-H1146
-
-
Yada, T.1
Shimokawa, H.2
Hiramatsu, O.3
Haruna, Y.4
Morita, Y.5
Kashihara, N.6
-
4
-
-
78650179147
-
MicroRNA: A matter of life or death
-
Wang Z. MicroRNA: A matter of life or death. World J Biol Chem 2010; 1: 41-54.
-
(2010)
World J Biol Chem
, vol.1
, pp. 41-54
-
-
Wang, Z.1
-
6
-
-
38349169664
-
Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?
-
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Gen 2008; 9: 102-114.
-
(2008)
Nat Rev Gen
, vol.9
, pp. 102-114
-
-
Filipowicz, W.1
Bhattacharyya, S.N.2
Sonenberg, N.3
-
7
-
-
66549125217
-
MicroRNAs: Regulating a change of heart
-
Barringhaus KG, Zamore PD. MicroRNAs: regulating a change of heart. Circulation 2009; 119: 2217-2224.
-
(2009)
Circulation
, vol.119
, pp. 2217-2224
-
-
Barringhaus, K.G.1
Zamore, P.D.2
-
9
-
-
77957243894
-
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease
-
Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122: S124-131.
-
(2010)
Circulation
, vol.122
, pp. S124-131
-
-
Hu, S.1
Huang, M.2
Li, Z.3
Jia, F.4
Ghosh, Z.5
Lijkwan, M.A.6
-
10
-
-
80053259947
-
MicroRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects
-
Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011; 301: H1519-H1530.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
, pp. H1519-H1530
-
-
Mutharasan, R.K.1
Nagpal, V.2
Ichikawa, Y.3
Ardehali, H.4
-
11
-
-
79551492488
-
Insulin says NO to cardiovascular disease
-
Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc Res 2011; 89: 516-524.
-
(2011)
Cardiovasc Res
, vol.89
, pp. 516-524
-
-
Yu, Q.1
Gao, F.2
Ma, X.L.3
-
12
-
-
0034610449
-
Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt
-
Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000; 102: 2873-2879.
-
(2000)
Circulation
, vol.102
, pp. 2873-2879
-
-
Aikawa, R.1
Nawano, M.2
Gu, Y.3
Katagiri, H.4
Asano, T.5
Zhu, W.6
-
13
-
-
0037905740
-
H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways
-
Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615-621.
-
(2003)
J Mol Cell Cardiol
, vol.35
, pp. 615-621
-
-
Kwon, S.H.1
Pimentel, D.R.2
Remondino, A.3
Sawyer, D.B.4
Colucci, W.S.5
-
14
-
-
7444264785
-
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: A focus on AKT
-
Ceci M, Ross J, Jr, Condorelli G. Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. J Mol Cell Cardiol 2004; 37: 905-912.
-
(2004)
J Mol Cell Cardiol
, vol.37
, pp. 905-912
-
-
Ceci, M.1
Ross, J.2
Condorelli, G.3
-
16
-
-
0345258505
-
Oxidative stress-induced signal transduction pathways in cardiac myocytes: Involvement of ROS in heart diseases
-
Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 2003; 5: 789-794.
-
(2003)
Antioxid Redox Signal
, vol.5
, pp. 789-794
-
-
Takano, H.1
Zou, Y.2
Hasegawa, H.3
Akazawa, H.4
Nagai, T.5
Komuro, I.6
-
17
-
-
0033731863
-
Participation of reactive oxygen species in PGF2alpha-induced apoptosis in rat luteal cells
-
Tanaka M, Miyazaki T, Tanigaki S, Kasai K, Minegishi K, Miyakoshi K, et al. Participation of reactive oxygen species in PGF2alpha-induced apoptosis in rat luteal cells. J Reprod Fertil 2000; 120: 239-245.
-
(2000)
J Reprod Fertil
, vol.120
, pp. 239-245
-
-
Tanaka, M.1
Miyazaki, T.2
Tanigaki, S.3
Kasai, K.4
Minegishi, K.5
Miyakoshi, K.6
-
18
-
-
0028085078
-
The insulin signaling system
-
White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269: 1-4.
-
(1994)
J Biol Chem
, vol.269
, pp. 1-4
-
-
White, M.F.1
Kahn, C.R.2
-
19
-
-
0028963084
-
Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
-
Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.
-
(1995)
Science
, vol.267
, pp. 2003-2006
-
-
Yao, R.1
Cooper, G.M.2
-
20
-
-
0031034574
-
Antiapoptotic signalling by the insulin-like growth factor i receptor, phosphatidylinositol 3-kinase, and Akt
-
Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997; 17: 1595-1606.
-
(1997)
Mol Cell Biol
, vol.17
, pp. 1595-1606
-
-
Kulik, G.1
Klippel, A.2
Weber, M.J.3
-
21
-
-
0030861078
-
Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials
-
Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1152-1156.
-
(1997)
Circulation
, vol.96
, pp. 1152-1156
-
-
Fath-Ordoubadi, F.1
Beatt, K.J.2
-
22
-
-
0032564373
-
Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group
-
Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corval á n R, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227-2234.
-
(1998)
Circulation
, vol.98
, pp. 2227-2234
-
-
Diaz, R.1
Paolasso, E.A.2
Piegas, L.S.3
Tajer, C.D.4
Moreno, M.G.5
Corvalán, R.6
-
23
-
-
84899720487
-
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement during Initial Assessment and Treatment in Emergency Care] Trial)
-
Selker HP, Udelson JE, Massaro JM, Ruthazer R, D ' Agostino RB, Griffith JL, et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial). Am J Cardiol 2014; 113: 1599-1605.
-
(2014)
Am J Cardiol
, vol.113
, pp. 1599-1605
-
-
Selker, H.P.1
Udelson, J.E.2
Massaro, J.M.3
Ruthazer, R.4
Agostino, R.B.D.5
Griffith, J.L.6
-
24
-
-
36849077497
-
Regulation of microRNA expression: The hypoxic component
-
Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M. Regulation of microRNA expression: the hypoxic component. Cell Cycle 2007; 6: 1426-1431.
-
(2007)
Cell Cycle
, vol.6
, pp. 1426-1431
-
-
Kulshreshtha, R.1
Ferracin, M.2
Negrini, M.3
Calin, G.A.4
Davuluri, R.V.5
Ivan, M.6
-
25
-
-
70450240736
-
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2
-
Kim HW, Haider HK, Jiang S, Calin GA, Davuluri RV, Ivan M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284: 33161-33168.
-
(2009)
J Biol Chem
, vol.284
, pp. 33161-33168
-
-
Kim, H.W.1
Haider, H.K.2
Jiang, S.3
Calin, G.A.4
Davuluri, R.V.5
Ivan, M.6
-
26
-
-
84867716694
-
MiR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia
-
Gou D, Ramchandran R, Peng X, Yao L, Kang K, Sarkar J, et al. miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am J Physiol Lung Cell Mol Physiol 2012; 303: L682-L691.
-
(2012)
Am J Physiol Lung Cell Mol Physiol
, vol.303
, pp. L682-L691
-
-
Gou, D.1
Ramchandran, R.2
Peng, X.3
Yao, L.4
Kang, K.5
Sarkar, J.6
|